AI assistant
Medtronic plc — Director's Dealing 2021
Jul 2, 2021
29841_dirs_2021-07-01_7f2bfd08-7917-4ff7-bf17-22882f643391.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-06-30
Reporting Person: Kirk Jennifer M (Chief Accounting Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 7104 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Performance Share Units | $ | Performance Share Units (3373) | Direct | ||
| Stock Option (Right to Buy) | $111.18 | 2031-02-01 | Ordinary Shares (11123) | Direct |
Footnotes
F1: Vests on August 3, 2023.
F2: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 3,373 shares will be issued. The actual number of shares to be issued could range from a low of 675 at minimum performance to a high of 6,746 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.